Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-27T22:54:52.293Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinicopathological features of mucoepidermoid carcinoma

Published online by Cambridge University Press:  22 January 2014

K Yamazaki ,
H Ohta ,
R Shodo ,
H Matsuyama  and
S Takahashi
K Yamazaki*
Affiliation:
Niigata Prefecture Head and Neck Malignant Tumour Registration Committee, Faculty of Medicine, Niigata University, Japan Department of Otorhinolaryngology, Faculty of Medicine, Niigata University, Japan
H Ohta
Affiliation:
Niigata Prefecture Head and Neck Malignant Tumour Registration Committee, Faculty of Medicine, Niigata University, Japan Department of Otorhinolaryngology, Faculty of Medicine, Niigata University, Japan
R Shodo
Affiliation:
Niigata Prefecture Head and Neck Malignant Tumour Registration Committee, Faculty of Medicine, Niigata University, Japan Department of Otorhinolaryngology, Faculty of Medicine, Niigata University, Japan
H Matsuyama
Affiliation:
Niigata Prefecture Head and Neck Malignant Tumour Registration Committee, Faculty of Medicine, Niigata University, Japan Department of Otorhinolaryngology, Faculty of Medicine, Niigata University, Japan
S Takahashi
Affiliation:
Niigata Prefecture Head and Neck Malignant Tumour Registration Committee, Faculty of Medicine, Niigata University, Japan Department of Otorhinolaryngology, Faculty of Medicine, Niigata University, Japan
*
Address for correspondence: Dr Keisuke Yamazaki, Department of Otorhinolaryngology, Faculty of Medicine, Niigata University, 1-757 Asahimachi-dori, Chuo-ku, Niigata-shi 951-8510, Japan Fax: +81 025 227 0786 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

We aimed to examine the clinical usefulness of a new World Health Organization classification scheme for salivary gland mucoepidermoid carcinoma, and to identify the factors most strongly associated with prognosis and outcome.

Methods:

The clinicopathological features of 45 patients who received treatment for mucoepidermoid carcinoma between 1986 and 2010 were retrospectively investigated.

Results:

The overall disease-specific 5-year survival rate was 81.8 per cent. The rate for patients with low-grade tumours (92.5 per cent) was significantly higher than that for patients with intermediate or high-grade tumours (52.2 per cent). Univariate analysis revealed that five factors were significantly associated with five-year survival: age, tumour stage classification, lymph node status, histological grade and treatment method. Four factors were significant in multivariate analysis: age, sex, tumour stage classification and lymph node status.

Conclusion:

The new World Health Organization classification was useful in predicting disease progression in patients with mucoepidermoid carcinoma. Patients with high-grade tumours or other prognostic factors positively associated with disease progression should be carefully evaluated and monitored.

Keywords

Carcinoma, MucoepidermoidWorld Health OrganizationPrognosis
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 128 , Issue 1 , January 2014 , pp. 91 - 95
Copyright
Copyright © JLO (1984) Limited 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Evans, HL. Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading. Am J Clin Pathol 1984;81:696–701Google Scholar
2Auclair, PL, Goode, RK, Ellis, GL. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Cancer 1992;69:2021–303.0.CO;2-7>CrossRefGoogle ScholarPubMed
3Spiro, RH, Huvos, AG, Berk, R, Strong, EW. Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am J Surg 1978;136:461–8Google Scholar
4Goode, RK, El-Naggar, AK. Mucoepidermoid carcinoma. In: World Health Organization. Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. Lyon: International Agency for Research on Cancer Press, 2005;219–20Google Scholar
5Seifelt, G. Histological Typing of Salivary Gland Tumours, 2nd edn.Heidelberg: Springer-Verlag, 1992Google Scholar
6McHugh, CH, Roberts, DB, El-Naggar, AK, Hanna, EY, Gerden, AS, Kies, MS et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012;118:3928–36Google Scholar
7Rapidis, AD, Givalos, N, Gakiopoulou, H, Stavrianos, SD, Faratzis, G, Lagogiannis, GA et al. Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients. Oral Oncol 2007;43:130–6Google Scholar
8Boahene, DK, Olsen, KD, Lewis, JE, Pinheiro, AD, Pankratz, VS, Bagniewski, SM. Mucoepidermoid carcinoma of the parotid gland: the Mayo clinic experience. Arch Otolaryngol Head Neck Surg 2004;130:849–56Google Scholar
9Lin, AC, Bhattacharyya, N. The utility of fine needle aspiration in parotid malignancy. Otolaryngol Head Neck Surg 2007;136:793–8CrossRefGoogle ScholarPubMed
10Stewart, CJ, Mackenzie, K, McGarry, GW, Mowat, A. Fine needle aspiration cytology of salivary gland: a review of 341 cases. Diagn Cytopathol 2000;22:139–46Google Scholar
11Al-Khafaji, BM, Nestok, BR, Katz, RL. Fine-needle aspiration of 154 parotid masses with histologic correlation: ten-year experience at the University of Texas M. D. Anderson Cancer Center. Cancer 1998;84:153–9Google Scholar
12Vander Poorten, VL, Balm, AJ, Hilgers, FJ, Tan, IB, Loftus-Coll, BM, Keus, RB et al. The development of a prognostic score for patients with parotid carcinoma. Cancer 1999;85:2057–67Google Scholar
13Luukkaa, H, Klemi, P, Leivo, I, Koivunen, P, Laranne, J, Makitie, A et al. Salivary gland cancer in Finland 1991-96: an evaluation of 237 cases. Acta Otolaryngol 2005;125:207–14Google Scholar
14Carrillo, JF, Vazquez, R, Ramirez-Ortega, MC, Cano, A, Ochoa-Carrillo, FJ, Onate-Ocana, LF. Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer 2007;109:2043–51CrossRefGoogle ScholarPubMed
15Calearo, C, Pastore, A, Storchi, OF. Parotid gland carcinoma: analysis of prognostic factors. Ann Otol Rhinol Laryngol 1998;107:969–73Google Scholar
16Ozawa, H, Tomita, T, Sakamoto, K, Tagawa, T, Fujii, R, Kanzaki, S et al. Mucoepidermoid carcinoma of the head and neck: clinical analysis of 43 patients. Jpn J Clin Oncol 2008;38:414–18Google Scholar
17Mendenhall, WM, Morris, CG, Amdur, RJ, Werning, JW, Villaret, DB. Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer 2005;103:2544–50Google Scholar
18Hosokawa, Y, Shirato, H, Kagei, K, Hashimoto, S, Nishioka, T, Tei, K et al. Role of radiotherapy for mucoepidermoid carcinoma of salivary gland. Oral Oncol 1999;35:105–11Google Scholar
19Laurie, SA, Licitra, L. Systemic therapy in palliative management of advanced salivary gland cancers. J Clin Oncol 2006;24:2673–8Google Scholar